(Q42548533)

2 November 2017

title

Plasma prolactin response to d-fenfluramine in obsessive-compulsive patients before and after fluvoxamine treatment (English)

1 reference

2 November 2017

1 reference

Monteleone P

1

1 reference

2 November 2017

Catapano F

series ordinal

2

1 reference

2 November 2017

Bortolotti F

series ordinal

3

1 reference

2 November 2017

Maj M

series ordinal

4

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 August 1997

1 reference

2 November 2017

published in

Biological Psychiatry

1 reference

2 November 2017

volume

42

1 reference

2 November 2017

issue

3

1 reference

2 November 2017

page(s)

175-180

1 reference

Prolactin and cortisol responses to MK-212, a serotonin agonist, in obsessive-compulsive disorder.

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900338-1

Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900338-1

Pharmacological characterization of serotonin receptors involved in the control of prolactin secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900338-1

From fenfluramine racemate to d-fenfluramine. Specificity and potency of the effects on the serotoninergic system and food intake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900338-1

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900338-1

Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900338-1

A rating scale for depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900338-1

Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900338-1

Serotonergic Function in Obsessive-Compulsive Disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900338-1

d- and l-isomers of fenfluramine differ markedly in their interaction with brain serotonin and catecholamines in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900338-1

Cortisol and prolactin responses to d-fenfluramine in non-depressed patients with obsessive-compulsive disorder: a comparison with depressed and healthy controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900338-1

The anterior pituitary responds normally to protirelin in obsessive-compulsive disorder: evidence to support a neuroendocrine serotonergic deficit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900338-1

Peripheral markers of serotonin and dopamine function in obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900338-1

Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5-hydroxytryptaminergic neurones. Studies with fenfluramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900338-1

Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900338-1

Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900338-1

High-affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive-compulsive patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900338-1

Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900338-1

Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900338-1

10.1016/S0006-3223(96)00338-1

7 January 2021

Identifiers

DOI

1 reference

2 November 2017

1 reference